The tracer lIICj-a-methyl-L-tryptophan (aMTP) has been used to measure brain serotonin synthesis rates with positron emission tomography (PET). To address questions about the accuracy of the kinetic model, e4C]aMTP was used to directly measure conversion to C4Cj-a-methyl-serotonin (aM5HT) in monkeys that had been previously studied with PET and [1 1C]aMTP. Four male, fasted, isoflurane-anes thetized rhesus monkeys were studied with C iC]aMTP and PET. Immediately after the initial 3-hour scan, a second dose of [llC]aMTP was coinjected with I mCi of C4C]aMTP, and additional PET data were collected, Approximately 90 minutes after the second aMTP administration, the animals were killed with an overdose of phenobarbital, and brain samples from 21 regions were taken and analyzed by HPLC. Minimal conver-Based on the work of Diksic et a!. (Diksic et a!., , 1991 , several groups, including ourselves, have attempted to use e I C]-a-methyl-L tryptophan (aMTP) and positron emission tomography (PET) imaging for the determination of brain serotonin synthesis rates (Chugani et a!.
sion of aMTP to aM5HT occurred; HPLC analysis of 14C radioactivity showed that greater than 96% of the total counts were in fractions corresponding to the aMTP peak. Brain con centrations of serotonin, tryptophan, 5-hydroxyindole-3-acetic acid, and aMTP also were determined f1uorometrically using external quantification. Patlak plots generated from PET im ages acquired over 3 hours showed no time period of linear increase, and final slopes were not significantly different from zero, consistent with the finding of minimal conversion to [14C] aM5HT. These data indicate that in the 3-hour period after injection, C lC]aMTP is acting predominantly as a tracer of tryptophan uptake, not serotonin synthesis. Key Words: Serotonin-Positron emission tomography-Rhesus mon keys-Pharmacokinetics-Brain-a-Methyl-L-tryptophan.
In theory, aMTP first acts as a tracer of tryptophan uptake into the brain. Then, in serotonergic neurons, aMTP is converted to a-methyl-serotonin (aM5HT). Because aM5HT is not a substrate for monoamine oxi dase, it accumulates in the brain. Data from rats indicate that the uptake of radioactivity given as [ 14 C]aMTP was irreversible (Missala and Sourkes, 1988) . Thus, by mea suring the accumulation of radioactivity in the brain over time, it may be possible to calculate the serotonin syn thesis rate based on the same model used to calculate glucose utilization with 2-deoxyglucose (Sokoloff et aI., 1977) . However, there are important kinetic differences between aMTP and 2-deoxyglucose, both in transport and metabolism resulting from differences in the trans porter, enzyme kinetics (Vm ax and Km), and substrate concentrations.
The model for aMTP or 2-deoxyglucose involves es timation of the rate of uptake (K*) into the trapped com partment, representing aM5HT or deoxyglucose-6phosphate, respectively. This measurement can be per formed once the precursor pool (i.e., the un metabolized tracer in the brain) reaches equilibrium with that in the plasma. At this time, the Patlak plot becomes linear, and the slope of this line, K*, can be determined (Patlak et al., 1983) . However, the half-life of exMTP in the precursor pool to reach equilibrium is much longer than that of deoxyglucose (Muzik et aI., 1997) , resulting from the lower extraction of exMTP from plasma. Thus, as shown by the nonlinearity, early postinjection data are not suit able for use in estimating K*. Based on PET scan data taken over a I-hour period after administration of [ ll C]exMTP to humans, Muzik et al. (1997) estimated the half-life of exMTP in the precursor pool to be 15 to 20 minutes. Therefore, the apparent steady-state between the precursor pool and plasma may not be achieved until approximately 80 minutes (five half-lives). In our previ ous study in rhesus monkeys, Patlak plot analysis of PET data showed no time periods of linearity over 90 minutes (Shoaf et aI., 1998) .
Unlike 2-deoxyglucose, which is rapidly phosphory lated to deoxyglucose-6-phosphate, the conversion of exMTP to exM5HT is slow. In rats, Diksic et al. (1990) showed that only 31 % of the radioactivity in the dorsal raphe nucleus was present as exM5HT at 60 minutes after injection of [ 14 C]exMTP. Gharib et al. (1999) report that, at 60 minutes after exMTP injection, the percentage of radioactivity present as exM5HT in the raphe dorsalis, raphe centralis, and the mesencephalic reticular forma tion was 20%, II %, and 4%, respectively. At 180 min utes, the percentage of exM5HT in each region was 52%, 28%, and 4%, respectively. These results, however, con flict with predictions of the percentage of radioactivity that is metabolized that can be inferred from the exMTP Patlak plots. Estimates of the amount of activity in the trapped or metabolized pool (i.e., exM5HT) can be made by multiplying the estimated Patlak K* by the integral of the plasma input function. Previous estimates of exM5HT from data obtained between 30 and 60 minutes, in hu mans and monkeys, suggest that exM5HT should account for a considerably higher percentage of the total counts than was found in the rat studies (Chugani et aI., 1998b; Shoaf et aI., 1998) . Patlak plots of PET data from mon keys, between 60 and 90 minutes, provide lower esti mates of exM5HT, but the values predicted still are higher than would be expected from the rat data. This inconsis tency between measurements of metabolized tracer and the model predictions of serotonin synthesis rate sug gests that the model estimates are incorrect, perhaps be cause the time for the precursor pool to reach equilibrium is significantly longer than previously estimated (Shoaf et al., 1998; Gharib et ai., 1999) .
We performed a PET study to further examine exMTP as a tracer for serotonin synthesis. Scanning for a longer period of time with a more sensitive instrument would permit maximum accumulation of exM5HT and determi nation of a truly linear portion of the Patlak plot. Thus, we performed an experiment in which four rhesus mon-keys, anesthetized with isot1urane, were scanned for 3 hours in a high-sensitivity three-dimensional PET scan ner after the administration of a usual tracer dose of r ll C]exMTP. Immediately after the first e l C]exMTP ad ministration, we performed a second PET scan for I hour after the administration of a mixture of [ 11 C]exMTP and [ 14 C]exMTP. Since the only way to assess the accumula tion of exM5HT is to measure its concentration after an administration of exMTP, the animals then were killed, and brain tissues were sampled for the determination of [ 14 C]exM5HT and [ 14 C]exMTP concentrations. This paired study design also permitted the assessment of any effect of the additional dose of unlabeled exMTP in the second run resulting from the coinjection of e 4 C]exMTP.
METHODS

Animals
Four male rhesus monkeys were individually housed accord ing to the National Institutes of Health Animal Care and Use Guidelines. All procedures were approved by the National In stitute on Alcohol Abuse and Alcoholism Animal Care and Use Committee (protocol LCS-82). Animals weighed 6.9 to 8.2 kg and were 12 to 20 years old. The day before the PET study, the animals were fasted with only water available from 7 PM. On the day of the study, animals were transported to a surgical suite, anesthetized with ketamine (10 mg/kg intramuscularly) and given intramuscular injections of penicillin G procaine/ benzathine (0.15 mLlkg) and glycopyrrolate (0.055 mg/kg). An intravenous catheter was inserted in the saphenous vein, and a drip of sterile physiologic saline was started. Sodium pentobar bital (9 to 13 mg/kg intravenously) was administered before the animal was intubated. The animals then were placed under inhalation anesthesia (isoflurane) for the insertion of a femoral artery catheter, which was sutured and taped in place after being flushed with I mL of 10 UlmL heparin. For transport to the PET suite, the animals were given another intramuscular dose of ketamine. Once in the PET suite, inhalation anesthesia with isoflurane was resumed. Heating pads were used to main tain body temperature. Electrocardiogram, blood pressure, re spiratory rate, and end-tidal Pco2 monitoring were used to regu late the depth of anesthesia. C 1 C]aMTP was administered at least 2.5 hours after the initial induction of anesthesia with ketamine so any effects of ketamine or pentobarbital would be minimal, and any medication effects would primarily result from isoflurane.
Imaging
A GE Advance scanner (General Electric, Waukesha, WI, U.S.A.) (4.25-mm slice separation, reconstructed resolution ap proximately 6 mm in all directions) was used with the inter plane septa removed. During the two PET procedures, the ani mals were positioned prone in a stereotaxic frame designed for use in the scanner. A lead shield, approximately 6-mm thick, was placed around the chest of the animal to minimize scatter and random counts from this region.
Scan f. A transmission scan was obtained for attenuation correction before injection of the tracer. Two injections of 15 mCi of eSO]water were performed, and 60-second scans were acquired. These images were averaged and used for image registration and region of interest placement. A 3-mL sample of arterial blood was taken for the determination of free and total plasma tryptophan. The radiopharmaceutical ["ClaMTP was prepared according to the method of Schmall et al. (1995) . The dose of II to IS mCi (specific activity Ci/mmol, mean 187, range 24 to 320) was injected intravenously through the saphe nous vein catheter over a I-minute period using an infusion pump. Scanning continued for 3 hours, and 30 arterial blood samples were drawn for the determination of [II ClaMTP whole blood and plasma concentration curves; each blood sample had a volume of 0.5 mL. Since no metabolites of aMTP are present in blood or plasma samples, samples were directly counted on a Packard Cobra Auto-gamma counter.
Scan 2. The second scan of I-hour duration was begun 20 to 30 minutes after the completion of the first scan. A mixture of [14ClaMTP and [ I I ClaMTP was administered intravenously over a 2-minute period using an infusion pump. The aMTP mixture contained I mCi of [14ClaMTP (specific activity 56 mCilmmol, radiochemical purity above 99%, 100% L form;
Moravek Biochemicals, Brea, CA, U.S.A.) and 10 to 17 mCi of ["CJaMTP (specific activity, Ci/mmol, mean 152, range 52 to 260) in IS to 20 mL of a solution of 5 mL of ethanol, S mL of water, and the rest, physiologic saline. Twenty-four arterial blood samples were taken and analyzed as described earlier.
Data analysis
Based on the model of Oiksic et al. (1990 Oiksic et al. ( , 1991 , the sero tonin synthesis rate is calculated as follows: R = K*' Cp/LC, where K* is the net influx constant of aMTP (ILLImin/mL), Cp is the free plasma tryptophan concentration (nmol/mL), and LC is the lumped constant with a value of 0.18 for rhesus monkeys (Shoaf and Schmall, 1996) . K* was calculated using a variant of the Patlak analysis (Patlak et aI., 1983) . The tissue concen tration data [Cj(t), nCi/mL tissue] from each pixel over the specified time range are fit to the following linear equation:
where C p (t) is the measured plasma concentration of aMTP, Cb(t) is the whole blood concentration, and Vc is the exchange able tissue volume (mL bloodlmL tissue). The fit was per formed pixel-by-pixel to estimate K* and Vc. and images of K* were obtained. To compare the data from this study to those obtained in our previous study (Shoaf et aI., 1998) , we repeated the analysis where we selected 30 to 60 minutes as the linear range.
Brains were outlined on the r'501water scans and coregis tered to the brain of one monkey by the gray scale matching technique (Thevenaz et aI., 1995); cubic spline interpolation was used to determine pixel values on the registered scans. Regions of interest (4 x 4 pixels, 2 mm/pixel) were placed on the average water scan, and the K* values for each region of interest were determined using the registered scans.
Curve fitting
Irregular regions of interest were drawn on cortical regions (occipital, parietal, temporal, and frontal) on the [1501water images, and time-activity curves were generated from the dy namic sequence of [I I ClaMTP images. An average cortical time-activity curve was produced from the individual cortical time-activity curves. These tissue data were fit to a four parameter model (Oiksic et aI., 1991; Muzik et aI., 1997) J Cereb Blood Flow Metab, Vol. 20, No. 2, 2000 where K I is the uptake rate constant (mLimin/mL), k2 is the tissue-to-blood clearance constant, k, is the rate constant of aMTP trapping, and Vb is the tissue blood volume. The first two terms in the model equation correspond to the sum of the trapped and exchangeable radioactivity in tissue, and the third term is the vascular radioactivity. All model solutions included integration of the model over the duration of each scan. Scan data were weighted by the inverse of the square of the data SO. The latter was estimated for each scan as the ratio of the whole brain mean activity to the square root of the noise-equivalent counts based on the relationship that the image coefficient of variation is inversely proportional to the square root of the noise-equivalent counts (Strother et aI., 1990) . Fits were per formed for time periods 0 to 60 minutes and 0 to 180 minutes for the first scan in each animal. Fits also were performed with k3 fixed to 0 (three-parameter model).
Brain sampling
At 60 minutes after the second aMTP injection, the animal was removed from the stereotactic head frame, 0.8 mL of ke tamine (intramuscularly) was administered, and the animal was transported to a pathology laboratory, At approximately 90 minutes after aMTP administration, an overdose of phenobar bital was administered intravenously, Dissection of the brain began 10 to 15 minutes later, after its removal from the cra nium, and was completed in 10 to IS minutes. Samples from 21 different regions (Table I) were taken and frozen at -80°C.
Chromatographic assays
Free and total plasma tryptophan concentrations were deter mined by HPLC with fluorometric detection according to Shoaf et al. (1998) .
Brain samples were analyzed for serotonin, a-methyl-5hydroxy tryptophan (aM5HTP), aM5HT, tryptophan, 5-hy droxyindole-3-acetic acid (5-HIAA), and aMTP concentrations using HPLC with fluorometric detection. Since detectable con centrations of 5-hydroxytryptophan (5-HTP) were not expected to be found, the HPLC separation was optimized for the other compounds, and quantitation of 5-HTP was not done.
Brain tissues were homogenized in a volume of buffer con sisting of 0.1 N perchloric acid, I % (volume [v]/v) ethanol, 0.02% ethylenediamine tetraacetic acid (weight/v), equal to the weight of the tissue rounded up to next highest 100 ILL. One half of the cerebellum, pons, medulla, and midbrain were ho mogenized after being sliced down the midline. Tissue weights ranged from 175 to 1500 mg; the median size was 500 mg, The homogenate then was centrifuged at 5000 x g for 10 minutes; the supernatant was removed and placed in a microfuge tube, which then was centrifuged at 12,000 x g for 3 minutes. One hundred fifty microliters of supernatant was injected onto a Nova-Pak C-18 column, 300 x 4.6 mm (Waters, Milford, MA, U.S.A.). The mobile phase consisted of 100 mmollL citrate, 100 mmollL sodium acetate, and 0.03 mmollL ethylenediamine tetraacetic acid buffer, methanol, and 4 N perchloric acid (ratio 94/5.5/0,5 v/v/v) run at 0.9 mLimin. External quantification was used. To determine calibration curves, an aliquot of stock solution of standards in homogenizing buffer (frozen at -80°C until day of assay) were diluted in water and then diluted 1:1 with homogenizing buffer; 150 ILL was injected. If the seroto nin peak was offscale, remaining supernatant was diluted with homogenizing buffer that had been diluted I: I with water, and ISO ILL was injected. Fluorometric recoveries of the com pounds of interest, except 5-HTP, were determined by spiking rat brain tissues that had been finely diced by razor blade. They then were homogenized as described earlier. The recovery of a-methyl compounds was more than 95%. The recovery of the * Values are the mean ± SD for 4 monkeys at 90 minutes after administration of 17.9 fLmol of (XMTP.
added non methyl compounds was more than 95% (data not shown).
The eluent from the HPLC was collected in I-minute frac tions. Ten milliliters of Bio-Safe II (Research Products Inter national, Corp., Mt. Prospect, IL, U.S.A.) was added to each fraction and counted four different times in a Scintillation counter (Beckman, model LS 6000) for 14C activity. Back ground counts were subtracted from reported disintegration per minute (DPM) values. Recovery of 14C from brain tissue was determined by spiking samples of finely diced cold monkey brain tissue with C4CjaMTP stock solution, homogenizing as described earlier, and counting the fractions of HPLC eluant. Recovery of C4ClaMTP was more than 96% (data not shown). Recovery of total 14C radioactivity was determined by com paring the total counts in the HPLC fractions to the total counts in the original brain homogenate supernatant and was found to be approximately 95%; the tissue pellet was found to contain less than 2% of the supernatant counts.
RESULTS
Total and free plasma tryptophan concentrations were measured in plasma samples taken before and immedi ately after the PET scans. Beginning concentrations were 25.9 ± 1.2 and 7.5 ± 2.7 nmol/mL, respectively. Ending concentrations were 24.3 ± 1.6 and 7.9 ± 3.5 nmol/mL, respectively. This confirms that the study was performed under conditions in which tryptophan concentrations were stabilized.
Mean concentrations of serotonin, 5-HIAA, trypto phan, and aMTP (pmol/mg wet tissue) for 21 brain re gions are presented in Table I . Because of the low spe cific activity of the [ 14 C]aMTP (56 mCi/mmol), 17.9 /Lmol of aMTP was administered to each animal, and this produced fluorometrically measurable brain tissue concentrations. However, aM5HTP or aM5HT concen trations in all tissues were below the level of detection, 0.2 pmol/mL and 10 pmol/mL, respectively. Tryptophan and aMTP brain concentrations were highly correlated with a range of r = 0.607 to 0.837 (p < 0.001). No other correlations were statistically significant.
Scintillation counting of I-minute fractions of HPLC eluant revealed that more than 96% of all counts were present in those fractions (20, 21, 22, 23) belonging to aMTP (Table 2 ). An average of 0.61 ± 0.07% of the counts were present in the solvent front (fractions 3 and 4, labeled as unknown I). Counts in these fractions also were present after injections of the standard and amounted to less than I % of the total counts (data not shown). An average of 2.02 ± 0.19% of the counts eluted in fractions 9 and 10 (labeled as unknown 2). Counts in these fractions were also present after injections of the standard and amounted to less than I % of the total counts (data not shown). Counts in fractions 11 and 12 were assigned to aM5HT (Fig. I) (note the log scale for y axis).
In cortical regions, aM5HT accounts for an average of 0.3% of the total 14 C radioactivity. The tissues with the highest radioactivity in fractions corresponding to the aM5HT peak were the midbrain and the pons. The dorsal raphe nucleus (an area reported to have a high serotonin synthesis rate ] is a structure centered on the midline approximately 2 mm wide in the midbrain of the rhesus monkey, so determining the percentage of total DPM associated with aM5HT (range 0.47% to 0.96%) in half of the midbrain would have diluted DPM found in the raphe nucleus. In a second analysis, the remaining half of two of the midbrains were dissected into three sections, approximately 2 mm wide, by cuts parallel to the midline. The percentage of total DPM associated with Cl'M5HT in the innermost section was increased compared with that found in the entire half of the midbrain by a factor of two to four (2.1 versus 0.52, and 0.95 versus 0.47). Since the raphe is reported to be approximately 2 mm wide centered on the midline, it is possible that the percentage of measured counts from Cl'M5HT still is 50% lower than what would be measured if the raphe nucleus had been analyzed free of other tissue.
Analysis of K* images K* values (derived from fits of data 30 to 60 minutes after injection) for the first and second PET scans are presented in Table 3 . No significant differences were seen between runs; thus, there was no measurable effect of the additional unlabeled rxMTP on the tracer uptake, as expected, or an effect of prolonged anesthesia. None of the regional K* values were significantly different from those given by Shoaf et al. (1998) .
Curve fitting Figure 2 shows an example of a fit to the mean cortical curve using the four-parameter model (solid line) and a three-parameter model with k3 fixed to 0 (dashed line).
Fits to the four-parameter model showed a statistically significant improvement over the three-parameter model by the F test (p < 0.01). However, both models show lack of fit, as evidenced by nonrandom residuals. This lack of fit remained, even when only 60 minutes of data were fitted. From the fits of the average cortex curves from 0 to 60 minutes, the parameter values (mean ± SD) were as follows: K I , 0.012 ± 0.003 mLimin/mL; k2' 0.036 ± 0.008 min-I ; k3' 0.020 ± 0.010 min-I ; Vb' 0.048 ± 0.018 mL/mL; and K*, 4.3 ± 1.7 J-lLiminimL. These fitted K* values agreed well with the Patlak fitted values (30 to 60 minutes) of 4.1 ± 1.1 J-lLimin/mL. These values are simi lar to those obtained by Muzik et al. (1997) in awake human subjects.
Ideally, the fitted parameters would be independent of the duration of the data used for fitting. However, on extending the fitting procedure to 180 minutes, there was a statistically significant change (p < 0.05, two-tailed t test) in all parameters: K I , 0.010 ± 0.002 mLimin/mL; k20 0.Ql8 ± 0.003 min-I ; k3, 0.003 ± 0.001 min -I ; Vb' 0.OS3 ± 0.0l7 mLlmL; and K*, 1.7 ± 0.7 J-lLimin/mL. This reflects decreases of 48%, 83%, and 61 % in k2, k3, and K*, respectively, suggesting that kinetic parameters in cluding K* values determined from only 60 minutes of data may be significantly overestimated.
Based on the fitted parameters, the model can predict the fraction of the total radioactivity that will be in the trapped pool at any time. From the parameters of the 6O-minute fit, the predicted fraction of metabolized tracer (i.e., rxMSHTP and rxMSHT) at 90 minutes was 76 ± 24%. From the parameters of the 180-minute fit, the predicted metabolized fraction at 90 minutes was much lower, 23 ± 6%. However, both predicted values were much higher than the 14C measured value of 0.3%. This suggests that none of the estimated model parameters (60-or l80-minute values) are valid. Figure 3 shows Patlak plots for 3 hours of scanning data (corresponding to 400 to 4S0 minutes of trans formed time) for each of the four animals (dashed lines) and the average (solid line). Previous analysis of these curves have used the time period of 30 to 60 minutes after injection, which corresponds to approximately 60 to 120 minutes of transformed time. Examination of this portion of the plot (without benefit of the remainder of the curve) could permit the assertion that this is the linear portion of the curve and is suitable for estimation of the uptake rate constant, K*. However, clearly as time pro ceeds, the Patlak curve continues to roll off, with mini mal or no positive slope in the final data values. Thus, Patlak slopes taken from 30 to 60 minutes will substan tially overestimate the true tracer uptake rate. Estimation of the final slope using values from 300 minutes of trans formed time on, leads to estimates of K* of O.S ± 0.7 J-lLimin/mL, which are not significantly different from zero; the average statistical uncertainty (standard error) of K* from the Patlak fits from 300 minutes of trans formed time on was 0.3 J-lLimin/mL. This final slope value is much lower than the value obtained from 30 to 60 minutes of approximately 4 J-lLimin/mL. 
Patlak analysis
DISCUSSION
In our previous PET study where [ II C]cxMTP was given to monkeys with CSF 5-HIAA concentrations ranging from 152 to 356 pmol/mL, we found that calcu lated serotonin synthesis rates were not correlated with 5-HIAA concentration, a marker of central serotonin ac tivity (Shoaf et al. 1998) . We also were concerned that (1) Patlak plots did not seem to have any linear portions, and (2) the predicted amounts of trapped radioactivity (e.g., cxM5HT concentrations) seemed too high when compared with actual [ 14 C]cxM5HT concentrations mea sured by Diksic et al. (1990) . Our doubts about the actual percentage of cxMTP converted to cxM5HT were con firmed when a rat study (Gharib et aI., 1999) found that Patlak estimates would be erroneous because of the slow equilibration of the precursor pool.
In our anesthetized monkeys, we found approximately 2% to 4% of the total radioactivity in the dorsal raphe nucleus was e 4 C]cxM5HT after 90 minutes. This is con siderably lower than the 31% (Diksic et aI., 1990) or 20% (Gharib et aI., 1999) reported for the awake rat 60 minutes after [ 14 C]cxMTP administration. It is doubtful that isoflurane anesthesia would suppress serotonin syn thesis rates to such a great extent. If serotonin synthesis rate is tightly coupled to cxMTP uptake and anesthesia does suppress serotonin synthesis rate, then K* should be lower in anesthetized subjects. However, Chugani et al. (1997) report no differences in the uptake rates of cxMTP (K*) in normal adults and children who were scanned without anesthesia or after the administration of either midazolam or phenobarbital (Nembutal). It is more likely that serotonin synthesis rates in larger animals are slower than those in rats and may be suppressed by anesthesia. Low oxygen tension, an inhibitor of tryptophan hydrox ylase activity, would not be a problem in these animals, since the isoflurane is carried in 100% oxygen, and P02 concentrations typically are near 400 mm Hg.
For PET scanning, cortical regions are most easily imaged. Accurate quantification of a region such as the dorsal raphe nucleus cannot be performed because of its small volume. Serotonin synthesis rates in cortical brain regions are reported to be lower than in dorsal raphe nucleus (Nagahiro et aI., 1991) . We found that cxM5HT associated radioactivity in cortical regions ranged from 0% to 0.63% of total DPM (see Table 1) ; therefore, only a tiny fraction of the PET signal in cortex is caused by metabolized cxMTP.
The 14 C data and the terminal Patlak slopes suggest that little [ II C]cxMTP is being metabolized into e l C]cxM5HT. If so, it would be expected that the time activity data would be well described by a model with a single-tissue compartment and three parameters (K I , k2' and Vb)' Although this model does not fit the data ex tremely well (Fig. 2, dashed line) , the fit is not poor. The estimates of the distribution volume (K l /k2) for thi, model were 0.73 ± 0.18 mLlmL, reasonable values for a substrate of the large neutral amino acid transporter. Fur thermore, adding the term k3 for irreversible trapping (Fig. 2, solid line) , while showing a statistically signifi cant improvement in the fit, does not solve all of the lack of fit in the data. Because of the lack of fit, the model parameters vary with the fitting period. It is likely that other factors such as tissue heterogeneity and the partial volume effect are contributing to the lack of fit. Unlike Chugani et al. (1998b) , we found no correla tion between serotonin concentration and K* values (Fig.  4) . We found that the pattern of distribution of serotonin and 5-HIAA concentrations (Table I) matches that found by Brown et al. (1979) for young adult rhesus monkeys; our values are slightly higher because of the older age of our monkeys. Brown et al. (1979) also report that, for rhesus monkeys treated with NSD-1015 (an amino acid decarboxylase inhibitor), "the accumulation of 5-HTP does not parallel serotonin levels." Therefore, it may be the case that serotonin concentration is not a good indi cator of serotonin synthesis rate.
The net influx of a tracer is measured from the linear portion of a Patlak plot. The plot becomes linear once the reversible compartments (e.g., unmetabolized cxMTP) reach equilibrium with the plasma. However, it is often difficult to precisely define the linear portion of a Pat lak plot. The rise and rollover of this curve toward its asymptotic slope may be slow, particularly for tracers with low transport rates. The kinetics of OlMTP are in deed slow, in part because of the poor blood-brain bar rier transport using the large neutral amino acid trans porter. Another PET tracer transported in this manner, [ 18 p]fluoro-DOPA, also is analyzed using Patlak plots (Martin et aI., 1989) and also demonstrates slow kinetics. A kinetic evaluation of the Patlak plot for [ 18 p]fluoro_ DOPA shows that the estimates of the uptake constant K* can be significantly biased if data are used before the unmetabolized pool has reached equilibrium (Yu et aI., 1995) . Based on the kinetic analysis of the [ 11 C]OlMTP data, it appears that the estimates of K* derived from 30 to 60 minutes after injection are significantly overesti mated because equilibrium of the pool of tissue [ 11 C]OlMTP has not been achieved.
After extending data collection to 180 minutes, we were unable to find a linear portion of the Patlak plot (Pig. 3). The final slope of this curve was small and was not statistically different from zero. These data suggest that the net synthesis rate of OlM5HT is small, if the assumptions of the Patlak analysis are correct. There are two major assumptions of the Patlak analysis: first, all [ 1I C]OlM5HT is trapped in the tissue during the time course of this study; second, that the measured input function is correct and there are no radioactive metabo lites in blood for 180 minutes. If either of these two assumptions is incorrect, this would flatten the Patlak plots and reduce or eliminate the terminal slope. In our previous study, we found no radioactive metabolites of aMTP in plasma (Shoaf et aI., 1998) . Our interpreta tion of the Patlak results is validated by the finding that less than I % of total radioactivity was present as e 4 C]OlM5HT in cortical regions. Thus, we conclude that the synthesis rate of OlM5HT is negligible during the 180-minute period of these studies.
In light of the small or nonexistent final uptake rate, the high correlation of OlMTP to tryptophan concentra tions, and the negligible presence of OlM5HT in the tis sue, these data demonstrate that [ 11 C]OlMTP is simply tracing the uptake of a large neutral amino acid (trypto phan) in a manner similar to [ 11 C]aminocyclohexanecar boxy late (Koeppe et a!., 1990 ) and 3-0-methyl-6-[ 18 p]fluoro-L-DOPA (Doudet et aI., 1991) . In this case, the Patlak plot shows an initial uptake rate dependent on the capacity and saturation of the large neutral amino acid transporter, and the ultimate equilibrium level (the asymptote in the Patlak plot) is controlled by the relative influx and efflux rates of the transporter, driven by the plasma and tissue concentrations of large neutral amino acids. We conclude that during the time frame of a typi-cal lie study, [ 11 C]OlMTP cannot be used to measure serotonin synthesis rates.
